There Are More Than 380 Protein Kinase Inhibitors for the Treatment of Cancer, from Early Preclinical to Marketed Drugs

May 12, 2008 6:51 AM EDT

DUBLIN, Ireland--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/reportinfo.asp?report_id=314549) has announced the addition of "Protein Kinase Inhibitors in Oncology: Drug Pipeline Update 2008" to their offering.

Protein kinase inhibitors such as Gleevec, Iressa and Tarceva have allowed the biotechnology industry to deliver on the promise of targeted cancer drugs. However, these three successful drugs are just the top of an emerging line of therapy. Given the fact that they all target tyrosine kinases and that kinase mutations can cause patients to become resistant to these drugs, there is plenty of room for more competition.

There are today more than 380 protein kinase inhibitors for the treatment of cancer, from early preclinical to marketed drugs. Protein Kinase Inhibitors in Oncology: Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 139 different targets. These targets are further categorized on the CD-ROM by 36 classifications of molecular function and with pathway referals to BioCarta, KEGG and NetPath. Read more below on how the Protein Kinase Inhibitors in Oncology: Drug Pipeline Update is organized.

How May Drug Pipeline Update Be of Use?

Show investors/board/management that you are right on top of drug development progress in your therapeutic area.

    Find competitors, collaborations partners, M&A candidates etc.

    Jump start competitive drug intelligence operations

    Excellent starting point for world wide benchmarking

    Compare portfolio and therapy focus with your peers

    Speed up pro-active in-/out licensing strategy work

Fast and easy way of tracking drugs using search engines; just one click from inside the application and you may search the World Wide Web and PubMed for any drug.

Drug Pipeline Update is delivered to you as a CD-ROM application, which requires no installation on your computer. Please read more about application features and system requirements below.

Drug Pipeline Update at a Glance

Investigators Includes more than 190 principal investigators plus their collaborators. There is direct access from inside the application to web pages of all principal investigators.

Note: You are able to sort and find drugs according to investigators and partners from drop-down menus in the application. You may also sort and find drugs according to country of investigator.

- Drug name & Synonyms Lists

- Developmental Stage (This Drug Pipeline Update Contains more than 380 PKI Drugs in Active Development and More than 930 Developmental Projects)

    15 marketed drugs

    greater than 50 projects in Phase III

    greater than 320 projects in Phase II

    greater than 250 projects in Phase I

    greater than 260 projects in Preclinical

- Indications (Included PKI drugs are in development for over 90 indications)

- Targets (Identified Drugs are Linked to more than 139 Different Targets, Divided into 36 Classifications of Molecular Function)

- Identified Targets (Categorized into 18 Different Primary and Alternate Sub-cellular Localizations)

    Application Features (Use 13 Different Parameters)

    - Drug status

    - Clinical Trial Status

    - Principle Investigator

    - Partners

    - Indication

    - Developmental Stage

    etc

    - Export and sharing of information

    System Requirements - AMD-Athlon/Pentium II PC

    - Windows 98/NT4/2000/ME/XP/VISTA

    - 8x-speed CD Rom drive

    - SVGA 16 bit display. (32 bit recommended)

    - 32 MB of available RAM (128 MB recommended)

    - Internet access (for related internet resources)

    For more information visit
http://www.researchandmarkets.com/reportinfo.asp?report_id=314549

Source: Research and Markets

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?